Biospecifics Technologies Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Biospecifics Technologies General Information

Description

BioSpecifics Technologies Corp is a biopharmaceutical company that specializes in collagenase for multiple indications. Injectable collagenase is marketed in various geographic regions, including the U.S., the EU, and Australia, under the Xiaflex name. The targeted diseases are Dupuytren's contracture and Peyronie's disease. The company is also researching the development of Xiaflex as a solution for new potential indications, such as uterine fibroids, adhesive capsulitis, cellulite, lateral hip fat, plantar fibromatosis, and human and canine lipomas.

Contact Information

Website
www.biospecifics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Delaware Corporate Center II
  • 2 Righter Parkway, Suite 200
  • Wilmington, DE 19803
  • United States
+1 (302)
Primary Industry
Pharmaceuticals
Acquirer
Endo International
Corporate Office
  • Delaware Corporate Center II
  • 2 Righter Parkway, Suite 200
  • Wilmington, DE 19803
  • United States
+1 (302)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biospecifics Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biospecifics Technologies‘s full profile, request access.

Request a free trial

Biospecifics Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
BioSpecifics Technologies Corp is a biopharmaceutical company that specializes in collagenase for multiple indications.
Pharmaceuticals
Wilmington, DE
9 As of 2019

San Rafael, CA
 

Tarrytown, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biospecifics Technologies Competitors (42)

One of Biospecifics Technologies’s 42 competitors is BioMarin Pharmaceutical, a Formerly PE-Backed company based in San Rafael, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
GlaxoSmithKline Consumer Nigeria Corporation Lagos, Nigeria
Arrowhead Pharmaceuticals Corporation Pasadena, CA
Nymox Pharmaceutical Corporation Saint Laurent, Canada
You’re viewing 5 of 42 competitors. Get the full list »

Biospecifics Technologies Patents

  • 60

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Biospecifics Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090123454-A1 Using collagenase injections to lyse the collagenous adhesions in the shoulder and treat adhesive capsulitis or frozen shoulder Active 21-Jan-2005
US-20170095542-A1 Reduction of lipoma tissue Inactive 14-Jun-2002
CA-2308842-A1 Amelioration of peyronie's disease Active 03-Jun-1999
CA-2308842-C Amelioration of peyronie's disease Inactive 03-Jun-1999
DE-10027521-A1 Improvement of peyronie's disease (penile fibromatosis) Inactive 03-Jun-1999 A61K38/4886
To view Biospecifics Technologies’s complete patent history, request access »

Biospecifics Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biospecifics Technologies FAQs

  • When was Biospecifics Technologies founded?

    Biospecifics Technologies was founded in 1990.

  • Where is Biospecifics Technologies headquartered?

    Biospecifics Technologies is headquartered in Wilmington, DE.

  • What is the size of Biospecifics Technologies?

    Biospecifics Technologies has 9 total employees.

  • What industry is Biospecifics Technologies in?

    Biospecifics Technologies’s primary industry is Pharmaceuticals.

  • Is Biospecifics Technologies a private or public company?

    Biospecifics Technologies is a Private company.

  • What is the current valuation of Biospecifics Technologies?

    The current valuation of Biospecifics Technologies is .

  • What is Biospecifics Technologies’s current revenue?

    The current revenue for Biospecifics Technologies is .

  • How much funding has Biospecifics Technologies raised over time?

    Biospecifics Technologies has raised $2.42M.

  • Who are Biospecifics Technologies’s competitors?

    BioMarin Pharmaceutical, Regeneron Pharmaceuticals, GlaxoSmithKline Consumer Nigeria, Arrowhead Pharmaceuticals, and Nymox Pharmaceutical are some of the 42 competitors of Biospecifics Technologies.

  • When was Biospecifics Technologies acquired?

    Biospecifics Technologies was acquired on 01-Dec-2020.

  • Who acquired Biospecifics Technologies?

    Biospecifics Technologies was acquired by Endo International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »